These results suggest that tumor PD-L2 expression may inhibit anti-cancer immunity against colon carcinoma, implying that tumor PD-L2 might be upregulated by other mechanisms, such as hypoxia. This evidence concerns the gene PDCD1LG2 and neoplasm.